Small-molecule agents for cancer immunotherapy

Small-molecule agents for cancer immunotherapy

Cancer immunotherapy, exemplified by the remarkable clinical benefits of the immune checkpoint blockade and chimeric antigen receptor T-cell therapy, is revolutionizing cancer therapy. They induce long-term tumor regression and overall survival benefit in many types of cancer. With the advances in o...

Full description

Bibliographic Details
Main Authors: Fang Wang, Kai Fu, Yujue Wang, Can Pan, Xueping Wang, Zeyu Liu, Chuan Yang, Ying Zheng, Xiaopeng Li, Yu Lu, Kenneth Kin Wah To, Chenglai Xia, Jianye Zhang, Zhi Shi, Zeping Hu, Min Huang, Liwu Fu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Cancer immunotherapy
Small-molecule agents
Immune checkpoints
Oncogenic signaling
Metabolic pathways
Cytokine/chemokine signaling
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383523004793

Internet

http://www.sciencedirect.com/science/article/pii/S2211383523004793

Similar Items